BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Neil Kumar. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Neil Kumar reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:BBIO / BridgeBio Pharma, Inc. Chief Executive Officer, Director 243,327
US:LIAN / LianBio - Depositary Receipt (Common Stock) Director 5,002,792
Chief Executive Officer, Director, 10% Owner 24,575,501
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Neil Kumar. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas BBIO / BridgeBio Pharma, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em BBIO / BridgeBio Pharma, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BBIO / BridgeBio Pharma, Inc. Insider Trades
Vendas Internas BBIO / BridgeBio Pharma, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em BBIO / BridgeBio Pharma, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2022-12-21 BBIO Kumar Neil 200,000 200,000 7 6.7400
2022-11-17 BBIO Kumar Neil 34,640 9.3997 34,640 9.3997 325,606

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BBIO / BridgeBio Pharma, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Neil Kumar conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-26 2026-05-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -800 243,327 -0.33 70.92 -56,735 17,256,483
2026-05-26 2026-05-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,250 244,127 -4.41 70.48 -792,916 17,206,413
2026-05-26 2026-05-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,072 255,377 -1.95 69.22 -351,102 17,678,090
2026-05-26 2026-05-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,725 260,449 -2.52 68.30 -459,334 17,789,318
2026-05-26 2026-05-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,256 267,174 -0.84 67.57 -152,435 18,052,600
2026-05-19 2026-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -36,236 269,430 -11.85 66.13 -2,396,287 17,817,406
2026-05-19 2026-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 6,519 305,666 2.18
2026-05-19 2026-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 11,553 299,147 4.02
2026-05-19 2026-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 19,599 287,594 7.31
2026-05-19 2026-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 33,544 267,995 14.31
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -950 4,358,447 -0.02 68.35 -64,930 297,889,828
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,076 4,359,397 -0.12 67.35 -341,846 293,585,771
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13,974 4,364,473 -0.32 66.65 -931,374 290,894,308
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -950 555,686 -0.17 68.35 -64,930 37,979,860
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,077 556,636 -0.90 67.35 -341,913 37,486,930
2026-05-11 2026-05-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13,973 561,713 -2.43 66.65 -931,307 37,438,452
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -449 4,378,447 -0.01 69.09 -31,022 302,511,720
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,334 4,378,896 -0.19 68.38 -569,858 299,417,961
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,217 4,387,230 -0.26 67.49 -757,090 296,115,650
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -450 575,686 -0.08 69.09 -31,091 39,774,779
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,333 576,136 -1.43 68.38 -569,790 39,394,739
2026-05-11 2026-05-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,217 584,469 -1.88 67.50 -757,091 39,448,735
2026-04-13 2026-04-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 4,398,447 -0.45 74.60 -1,492,076 328,140,860
2026-04-13 2026-04-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 595,686 -3.25 74.60 -1,492,096 44,441,035
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,800 4,418,447 -0.18 75.53 -589,124 333,719,558
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,128 4,426,247 -0.12 74.57 -382,379 330,051,517
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,072 4,431,375 -0.16 73.64 -520,801 326,338,420
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,500 615,686 -1.20 75.55 -566,661 46,518,033
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,300 623,186 -0.84 74.60 -395,403 46,492,418
2026-04-13 2026-04-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,200 628,486 -1.13 73.64 -530,240 46,284,474
2026-03-16 2026-03-13 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -9,759 4,438,447 -0.22 69.23 -675,568 307,251,937
2026-03-16 2026-03-13 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10,241 4,448,206 -0.23 68.39 -700,345 304,196,795
2026-03-16 2026-03-13 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10,310 635,686 -1.60 69.20 -713,449 43,989,280
2026-03-16 2026-03-13 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -9,690 645,996 -1.48 68.36 -662,441 44,162,483
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -300 4,458,447 -0.01 70.15 -21,045 312,760,057
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,815 4,458,747 -0.13 69.29 -402,929 308,952,376
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13,885 4,464,562 -0.31 68.47 -950,687 305,682,310
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -300 655,686 -0.05 70.15 -21,045 45,996,373
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,363 655,986 -0.81 69.32 -371,750 45,471,375
2026-03-16 2026-03-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,337 661,349 -2.12 68.48 -981,809 45,289,709
2026-02-23 2026-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -602 234,451 -0.26 72.80 -43,826 17,068,267
2026-02-23 2026-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,528 235,053 -3.50 72.08 -614,702 16,942,714
2026-02-23 2026-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -18,923 243,581 -7.21 71.03 -1,344,190 17,302,703
2026-02-18 2026-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -30,970 262,504 -10.55 75.25 -2,330,492 19,753,426
2026-02-18 2026-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 11,554 293,474 4.10
2026-02-18 2026-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 19,600 281,920 7.47
2026-02-18 2026-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 33,544 262,320 14.66
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3,961 4,478,447 -0.09 73.25 -290,145 328,048,482
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4,404 4,482,408 -0.10 72.65 -319,938 325,634,390
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3,775 4,486,812 -0.08 71.46 -269,754 320,619,061
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,860 4,490,587 -0.17 70.70 -555,706 317,486,746
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3,994 675,686 -0.59 73.25 -292,574 49,496,364
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4,484 679,680 -0.66 72.64 -325,695 49,368,557
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3,716 684,164 -0.54 71.44 -265,477 48,877,771
2026-02-12 2026-02-11 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,806 687,880 -1.12 70.69 -551,796 48,625,343
2026-02-12 2026-02-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,960 4,498,447 -0.13 72.27 -430,751 325,119,409
2026-02-12 2026-02-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,040 4,504,407 -0.31 71.80 -1,008,006 323,395,252
2026-02-12 2026-02-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,799 695,686 -0.83 72.28 -419,165 50,285,784
2026-02-12 2026-02-10 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,201 701,485 -1.98 71.80 -1,019,657 50,367,886
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,855 4,518,447 -0.04 78.10 -144,882 352,906,525
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10,677 4,520,302 -0.24 77.46 -827,016 350,132,196
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,067 4,530,979 -0.13 76.53 -464,289 346,742,230
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,401 4,537,046 -0.03 75.61 -105,928 343,040,604
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -375 715,686 -0.05 78.19 -29,322 55,960,920
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10,519 716,061 -1.45 77.61 -816,365 55,572,492
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,955 726,580 -0.95 76.72 -533,569 55,741,256
2026-01-12 2026-01-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,151 733,535 -0.29 75.75 -162,943 55,566,743
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -300 4,538,447 -0.01 75.20 -22,561 341,306,191
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,135 4,538,747 -0.18 74.38 -605,061 337,580,655
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,565 4,546,882 -0.25 73.65 -851,811 334,896,956
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -400 735,686 -0.05 75.16 -30,064 55,294,307
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,085 736,086 -1.09 74.38 -601,340 54,748,089
2026-01-12 2026-01-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,515 744,171 -1.52 73.64 -848,018 54,804,176
2025-12-16 2025-12-15 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,700 228,776 -0.74 75.24 -127,910 17,213,381
2025-12-16 2025-12-15 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -28,311 230,476 -10.94 74.60 -2,111,992 17,193,440
2025-12-16 2025-12-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -30,964 258,787 -10.69 75.15 -2,326,945 19,447,843
2025-12-16 2025-12-12 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 60,975 289,751 26.65
2025-12-08 2025-12-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,712 4,558,447 -0.17 73.75 -568,758 336,184,555
2025-12-08 2025-12-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,288 4,566,159 -0.27 73.04 -897,529 333,517,276
2025-12-08 2025-12-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,483 755,686 -0.98 73.76 -551,951 55,739,928
2025-12-08 2025-12-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,517 763,169 -1.61 73.05 -914,324 55,746,901
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,700 4,578,447 -0.12 74.80 -426,358 342,466,004
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,200 4,584,147 -0.27 74.42 -907,970 341,169,639
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,100 4,596,347 -0.05 73.16 -153,626 336,247,603
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,708 775,686 -0.73 74.80 -426,939 58,018,675
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,192 781,394 -1.54 74.42 -907,381 58,154,701
2025-12-08 2025-12-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,100 793,586 -0.26 73.16 -153,638 58,059,625
2025-11-24 2025-11-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,456 228,776 -2.33 66.71 -363,986 15,262,310
2025-11-24 2025-11-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,299 234,232 -5.75 65.90 -942,361 15,436,826
2025-11-24 2025-11-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,401 248,531 -2.51 64.97 -415,877 16,147,208
2025-11-18 2025-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -32,855 254,932 -11.42 66.39 -2,181,243 16,924,935
2025-11-18 2025-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 11,554 287,787 4.18
2025-11-18 2025-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 19,599 276,233 7.64
2025-11-18 2025-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 33,544 256,634 15.04
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -220 795,686 -0.03 62.79 -13,815 49,963,988
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,546 795,906 -0.94 61.87 -466,839 49,239,282
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,234 803,452 -1.50 61.13 -747,862 49,114,860
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -200 4,598,447 0.00 62.80 -12,561 288,805,464
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,308 4,598,647 -0.16 61.87 -452,156 284,524,728
2025-11-10 2025-11-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,492 4,605,955 -0.27 61.14 -763,762 281,608,549
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 815,686 -0.01 64.39 -6,439 52,522,022
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,371 815,786 -0.90 63.56 -468,472 51,848,177
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,529 823,157 -1.50 62.91 -788,184 51,783,819
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 4,618,447 0.00 64.39 -6,439 297,381,802
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,324 4,618,547 -0.16 63.55 -465,416 293,493,421
2025-11-10 2025-11-06 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,576 4,625,871 -0.27 62.91 -791,166 291,017,245
2025-10-10 2025-10-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 835,686 -2.34 54.80 -1,096,046 45,797,515
2025-10-10 2025-10-09 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 835,686 -2.34 54.80 -1,096,046 45,797,515
2025-10-10 2025-10-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,295 855,686 -1.30 55.09 -622,226 47,138,544
2025-10-10 2025-10-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,705 866,981 -0.99 54.39 -473,450 47,153,623
2025-10-10 2025-10-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,294 4,658,447 -0.24 55.09 -622,171 256,627,323
2025-10-10 2025-10-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,706 4,669,741 -0.19 54.39 -473,504 253,978,807
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -800 875,686 -0.09 53.80 -43,040 47,111,381
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16,900 876,486 -1.89 53.16 -898,450 46,596,362
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,300 893,386 -0.26 51.96 -119,514 46,422,570
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -900 4,678,447 -0.02 53.80 -48,424 251,721,034
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16,800 4,679,347 -0.36 53.16 -893,125 248,764,381
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,300 4,696,147 -0.05 51.95 -119,496 243,986,439
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,442 895,686 -0.60 51.85 -282,187 46,444,454
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,558 901,128 -1.59 51.16 -744,739 46,098,735
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,475 4,698,447 -0.12 51.85 -283,902 243,634,680
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14,525 4,703,922 -0.31 51.15 -742,960 240,607,492
2025-08-22 2025-08-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -428 223,090 -0.19 49.25 -21,079 10,987,272
2025-08-22 2025-08-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25,728 223,518 -10.32 48.81 -1,255,848 10,910,472
2025-08-19 2025-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -32,855 249,246 -11.65 51.32 -1,686,119 12,791,305
2025-08-19 2025-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 64,697 282,101 29.76
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,205 915,686 -0.89 46.71 -383,252 42,771,327
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,205 915,686 -0.89 46.71 -383,252 42,771,327
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,795 923,891 -1.26 45.88 -541,162 42,388,673
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,795 923,891 -1.26 45.88 -541,162 42,388,673
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13,216 935,686 -1.39 45.64 -603,152 42,702,838
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13,216 935,686 -1.39 45.64 -603,152 42,702,838
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,784 948,902 -0.71 45.09 -305,909 42,788,553
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,784 948,902 -0.71 45.09 -305,909 42,788,553
2025-07-03 2025-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 955,686 -2.05 42.73 -854,514 40,832,353
2025-07-03 2025-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,000 4,758,447 -0.42 42.73 -854,536 203,313,213
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,600 975,686 -0.16 42.89 -68,628 41,849,612
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -18,400 977,286 -1.85 42.50 -782,092 41,539,541
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,700 4,778,447 -0.04 42.88 -72,903 204,919,399
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -18,300 4,780,147 -0.38 42.50 -777,777 203,163,418
2025-05-20 2025-05-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75,000 4,798,447 -1.54 33.40 -2,504,978 160,266,690
2025-05-20 2025-05-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -400 217,404 -0.18 33.75 -13,499 7,336,841
2025-05-20 2025-05-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25,756 217,804 -10.57 33.32 -858,265 7,257,861
2025-05-20 2025-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -32,854 243,560 -11.89 33.84 -1,111,779 8,242,070
2025-05-20 2025-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 64,696 276,414 30.56
2025-04-24 2025-04-22 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75,000 4,873,447 -1.52 34.11 -2,558,025 166,218,657
2025-03-27 2025-03-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75,000 4,948,447 -1.49 36.87 -2,764,942 182,428,952
2025-02-27 2025-02-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -37,101 5,023,447 -0.73 33.79 -1,253,524 169,726,199
2025-02-27 2025-02-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -37,899 5,060,548 -0.74 33.36 -1,264,447 168,838,099
2025-02-19 2025-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -76 211,718 -0.04 36.56 -2,779 7,740,410
2025-02-19 2025-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -31,467 211,794 -12.94 36.14 -1,137,246 7,654,426
2025-02-19 2025-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23,996 243,261 -8.98 34.90 -837,460 8,489,809
2025-02-19 2025-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55,539 267,257 26.23
2025-01-30 2025-01-29 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4,000 5,098,447 -0.08 36.82 -147,284 187,729,917
2025-01-30 2025-01-29 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -269,068 5,102,447 -5.01 36.34 -9,777,985 185,423,944
2025-01-30 2025-01-28 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -326,932 5,371,515 -5.74 36.29 -11,863,381 194,916,165
2024-12-27 2024-12-24 4 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 4,685,725 5,698,447 462.69
2024-12-27 2024-12-24 4 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -4,685,725 211,718 -95.68
2024-11-20 2024-11-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,875 4,897,443 -0.04 22.76 -42,680 111,478,046
2024-11-20 2024-11-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25,514 4,899,318 -0.52 22.39 -571,146 109,674,173
2024-11-19 2024-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -28,148 4,924,832 -0.57 23.72 -667,671 116,817,015
2024-11-19 2024-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55,537 4,952,980 1.13
2024-08-20 2024-08-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,197 4,897,443 -0.23 25.13 -281,367 123,066,866
2024-08-20 2024-08-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16,192 4,897,443 -0.33 24.39 -394,889 119,438,350
2024-08-20 2024-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -28,148 4,924,832 -0.57 24.40 -686,811 120,165,901
2024-08-20 2024-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55,537 4,952,980 1.13
2024-05-17 2024-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -30,748 4,897,443 -0.62 31.04 -954,418 152,016,631
2024-05-17 2024-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 60,667 4,928,191 1.25
2024-02-21 2024-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -47,922 4,867,524 -0.97 37.21 -1,783,178 181,120,568
2024-02-21 2024-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102,249 4,915,446 2.12
2023-11-20 2023-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -200 4,813,197 0.00 29.55 -5,910 142,229,971
2023-11-20 2023-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51,352 4,813,397 -1.06 29.10 -1,494,128 140,049,636
2023-11-20 2023-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50,697 4,864,749 -1.03 28.86 -1,463,115 140,396,656
2023-11-20 2023-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102,249 4,915,446 2.12
2023-08-18 2023-08-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51,552 4,813,197 -1.06 28.59 -1,473,784 137,601,120
2023-08-18 2023-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50,698 4,864,749 -1.03 29.80 -1,510,800 144,969,520
2023-08-18 2023-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102,250 4,915,447 2.12
2023-05-18 2023-05-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51,552 4,813,197 -1.06 14.01 -722,218 67,430,483
2023-05-18 2023-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50,697 4,864,749 -1.03 14.09 -714,321 68,544,313
2023-05-18 2023-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102,249 4,915,446 2.12
2023-05-05 2023-05-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120,000 1,012,722 -10.59 14.18 -1,701,744 14,361,613
2023-04-07 2023-04-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120,000 1,132,722 -9.58 15.46 -1,855,656 17,516,186
2023-03-03 2023-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120,000 1,252,722 -8.74 10.96 -1,315,224 13,730,084
2023-02-21 2023-02-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -44,798 4,813,197 -0.92 12.70 -569,073 61,142,523
2023-02-21 2023-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23,908 4,857,995 -0.49 12.64 -302,197 61,405,057
2023-02-21 2023-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68,706 4,881,903 1.43
2023-02-06 2023-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120,000 1,372,722 -8.04 11.01 -1,320,696 15,107,904
2023-01-06 2023-01-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120,000 1,492,722 -7.44 7.67 -920,856 11,454,850
2022-12-21 2022-12-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale -200,000 995,686 -16.73
2022-11-18 2022-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale -34,640 4,813,197 -0.71 9.40 -325,606 45,242,608
2022-11-18 2022-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -34,066 4,847,837 -0.70 9.64 -328,396 46,733,149
2022-11-18 2022-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68,706 4,881,903 1.43
2022-08-18 2022-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -27,697 4,813,197 -0.57 11.08 -306,883 53,330,223
2022-08-18 2022-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68,705 4,840,894 1.44
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -61,182 428,274 -12.50
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2,394 26,336 -8.33
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 41,035 -11.11
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23,759 4,772,189 -0.50 6.74 -160,136 32,164,554
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68,705 4,795,948 1.45
2022-03-18 2022-03-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 489,456 489,456
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2,394 28,730 -7.69
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,130 46,164 -10.00
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3,085 4,727,243 -0.07 8.84 -27,271 41,788,828
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7,524 4,730,328 0.16
2021-12-07 2021-12-03 4 BBIO BridgeBio Pharma, Inc.
Stock Option (right to buy)
A - Award 786,072 786,072
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2,394 31,124 -7.14
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 51,294 -9.09
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3,730 4,722,804 -0.08 47.25 -176,242 223,152,489
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7,523 4,726,534 0.16
2021-11-09 3/A LIAN LianBio
Ordinary Shares
5,002,792
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2,394 33,518 -6.67
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 56,423 -8.33
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3,730 4,719,011 -0.08 49.48 -184,560 233,496,664
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7,523 4,722,741 0.16
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2,394 35,912 -6.25
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,130 61,552 -7.69
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3,731 4,715,218 -0.08 53.66 -200,205 253,018,598
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7,524 4,718,949 0.16
2021-02-18 2021-02-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes 16,000 4,711,425 0.34 62.50 1,000,000 294,464,062
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 66,682 -7.14
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -2,139 4,695,425 -0.05 64.98 -138,992 305,108,716
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5,129 4,697,564 0.11
2021-02-12 2021-02-10 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 38,306 38,306
2021-02-12 2021-02-10 4 BBIO BridgeBio Pharma, Inc.
Stock Option (Right to Buy)
A - Award 225,971 225,971
2021-02-12 2020-11-24 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 268,000 1,195,686 28.89
2021-02-12 2020-11-24 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -472,650 1,612,722 -22.67
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 71,811 -6.67
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -1,774 4,692,435 -0.04 44.33 -78,641 208,015,644
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5,129 4,694,209 0.11
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5,129 76,940 -6.25
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -1,774 4,689,080 -0.04 28.53 -50,612 133,779,452
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5,129 4,690,854 0.11
2020-08-05 2020-08-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,759 2,085,372 -0.32 27.36 -184,914 57,052,024
2020-08-05 2020-08-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,184 2,092,131 -0.34 26.70 -191,846 55,869,522
2020-08-05 2020-08-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3,040 2,099,315 -0.14 28.12 -85,498 59,041,975
2020-08-05 2020-08-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -63,017 2,102,355 -2.91 27.23 -1,715,808 57,242,291
2020-07-06 2020-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -56,445 2,165,372 -2.54 30.22 -1,706,022 65,447,286
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,700 2,221,817 -0.12 32.42 -87,520 72,020,198
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -33,700 2,224,517 -1.49 31.67 -1,067,343 70,454,680
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -50,625 2,258,217 -2.19 30.63 -1,550,472 69,161,509
2020-06-10 2020-06-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10,600 2,308,842 -0.46 30.01 -318,125 69,292,504
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 82,069 82,069
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Stock Option (Right to Buy)
A - Award 590,551 590,551
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,930 2,319,442 -0.26 30.05 -178,173 69,690,186
2020-06-03 2020-06-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8,709 2,325,372 -0.37 29.71 -258,711 69,077,966
2020-06-03 2020-06-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -71,291 2,334,081 -2.96 29.13 -2,076,678 67,990,846
2020-05-06 2020-05-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -34,834 2,405,372 -1.43 31.23 -1,088,012 75,129,870
2020-05-06 2020-05-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -44,766 2,440,206 -1.80 30.86 -1,381,470 75,304,269
2020-05-05 2020-05-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -33,974 2,484,972 -1.35 29.77 -1,011,494 73,984,077
2020-05-05 2020-05-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,706 2,518,946 -0.23 29.13 -166,191 73,365,814
2020-05-05 2020-05-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4,098 2,524,652 -0.16 29.78 -122,055 75,194,235
2020-05-05 2020-05-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -36,622 2,528,750 -1.43 29.06 -1,064,345 73,493,061
2020-04-09 2020-04-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,805 2,565,372 -0.07 25.48 -45,983 65,353,878
2020-04-06 2020-04-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 2,567,177 0.00 25.10 -2,510 64,436,143
2020-04-06 2020-04-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -200 2,567,277 -0.01 25.09 -5,018 64,412,980
2020-04-03 2020-04-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -15,778 2,567,477 -0.61 25.04 -395,103 64,293,219
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1,382 2,583,255 -0.05 28.20 -38,979 72,860,191
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,976 2,584,637 -0.50 27.45 -356,252 70,960,433
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20,040 2,597,613 -0.77 26.38 -528,623 68,520,875
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -27,719 2,617,653 -1.05 25.52 -707,508 66,813,760
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -201 2,645,372 -0.01 33.22 -6,677 87,880,581
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12,090 2,645,573 -0.45 32.60 -394,105 86,239,330
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7,756 2,657,663 -0.29 31.76 -246,365 84,419,336
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -995 2,665,419 -0.04 33.33 -33,159 88,828,020
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -59,305 2,666,414 -2.18 32.53 -1,929,411 86,748,313
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -39,653 2,725,719 -1.43 31.88 -1,264,312 86,907,915
2020-02-14 2019-12-30 5/A BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 66,730 4,685,725 1.44
2020-02-14 2019-12-30 5/A BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -400,375 0 -100.00
2020-02-13 2019-12-30 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 66,730 4,685,365 1.44
2020-02-13 2019-12-30 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -400,375 0 -100.00
2020-02-07 2020-02-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -30,893 2,765,372 -1.10 34.87 -1,077,390 96,442,072
2020-02-05 2020-02-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -54,951 2,796,265 -1.93 34.55 -1,898,387 96,602,287
2020-02-05 2020-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2,100 2,851,216 -0.07 35.20 -73,914 100,354,820
2020-02-05 2020-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -32,056 2,853,316 -1.11 34.92 -1,119,309 99,630,091
2020-01-06 2020-01-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6,668 2,885,372 -0.23 32.88 -219,250 94,873,628
2020-01-06 2020-01-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -77,271 2,892,040 -2.60 32.14 -2,483,706 92,958,263
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 2,969,311 0.00 35.17 -3,517 104,430,668
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5,077 2,969,411 -0.17 34.19 -173,560 101,511,097
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -19,793 2,974,488 -0.66 33.41 -661,342 99,386,270
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11,091 2,994,281 -0.37 32.55 -361,042 97,471,931
2019-07-08 2019-07-03 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 882,353 24,575,501 3.72 29.90 26,382,796 734,819,768
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -1,907,102 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -2,744,459 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -927,686 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -1,742,631 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Series B Units
M - Exercise -400,375 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Units
M - Exercise -906,905 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Units
M - Exercise -323,270 0 -100.00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 927,686 927,686
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 400,375 400,375
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 1,907,102 7,624,367 33.36
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 2,744,459 5,717,265 92.32
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 1,742,631 2,972,806 141.66
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 906,905 1,230,175 280.54
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 323,270 323,270
2019-06-27 3 BBIO BridgeBio Pharma, Inc.
No securities beneficially owned.
0
2019-05-29 2019-05-24 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 1,103,848 23,693,148 4.89 25.93 28,622,779 614,363,328
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series Seed Preferred Stock
C - Conversion -12,832,123 0 -100.00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -2,909,029 0 -100.00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
X - Other 332,262 2,909,029 12.89
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Warrants
X - Other -332,262 0 -100.00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 1,000,000 19,614,655 5.37 17.00 17,000,000 333,449,135
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
F - Taxes -211,762 18,614,655 -1.12 17.00 -3,599,954 316,449,135
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
C - Conversion 18,826,417 18,826,417
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)